BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 9234717)

  • 1. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity.
    Bonita DP; Miyake S; Lupher ML; Langdon WY; Band H
    Mol Cell Biol; 1997 Aug; 17(8):4597-610. PubMed ID: 9234717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cbl-mediated negative regulation of platelet-derived growth factor receptor-dependent cell proliferation. A critical role for Cbl tyrosine kinase-binding domain.
    Miyake S; Mullane-Robinson KP; Lill NL; Douillard P; Band H
    J Biol Chem; 1999 Jun; 274(23):16619-28. PubMed ID: 10347229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells.
    Lupher ML; Reedquist KA; Miyake S; Langdon WY; Band H
    J Biol Chem; 1996 Sep; 271(39):24063-8. PubMed ID: 8798643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
    Bowtell DD; Langdon WY
    Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The c-Cbl oncoprotein.
    Lupher ML; Andoniou CE; Bonita D; Miyake S; Band H
    Int J Biochem Cell Biol; 1998 Apr; 30(4):439-44. PubMed ID: 9675877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323.
    Lupher ML; Rao N; Lill NL; Andoniou CE; Miyake S; Clark EA; Druker B; Band H
    J Biol Chem; 1998 Dec; 273(52):35273-81. PubMed ID: 9857068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cbl protooncogene product: from an enigmatic oncogene to center stage of signal transduction.
    Miyake S; Lupher ML; Andoniou CE; Lill NL; Ota S; Douillard P; Rao N; Band H
    Crit Rev Oncog; 1997; 8(2-3):189-218. PubMed ID: 9570294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oncogenic 70Z Cbl mutation blocks the phosphotyrosine binding domain-dependent negative regulation of ZAP-70 by c-Cbl in Jurkat T cells.
    van Leeuwen JE; Paik PK; Samelson LE
    Mol Cell Biol; 1999 Oct; 19(10):6652-64. PubMed ID: 10490604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological function of PDGF-induced PI-3 kinase activity: its role in alpha PDGF receptor-mediated mitogenic signaling.
    Yu JC; Gutkind JS; Mahadevan D; Li W; Meyers KA; Pierce JH; Heidaran MA
    J Cell Biol; 1994 Oct; 127(2):479-87. PubMed ID: 7929590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis.
    Yokouchi M; Wakioka T; Sakamoto H; Yasukawa H; Ohtsuka S; Sasaki A; Ohtsubo M; Valius M; Inoue A; Komiya S; Yoshimura A
    Oncogene; 1999 Jan; 18(3):759-67. PubMed ID: 9989826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene.
    Thien CB; Langdon WY
    Oncogene; 1997 May; 14(18):2239-49. PubMed ID: 9174060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine phosphorylation of Cbl upon epidermal growth factor (EGF) stimulation and its association with EGF receptor and downstream signaling proteins.
    Fukazawa T; Miyake S; Band V; Band H
    J Biol Chem; 1996 Jun; 271(24):14554-9. PubMed ID: 8662998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leucine zipper-mediated homodimerization of the adaptor protein c-Cbl. A role in c-Cbl's tyrosine phosphorylation and its association with epidermal growth factor receptor.
    Bartkiewicz M; Houghton A; Baron R
    J Biol Chem; 1999 Oct; 274(43):30887-95. PubMed ID: 10521482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in substrate specificities of alpha and beta platelet-derived growth factor (PDGF) receptors. Correlation with their ability to mediate PDGF transforming functions.
    Heidaran MA; Beeler JF; Yu JC; Ishibashi T; LaRochelle WJ; Pierce JH; Aaronson SA
    J Biol Chem; 1993 May; 268(13):9287-95. PubMed ID: 8387491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cbl phosphotyrosine-binding domain selects a D(N/D)XpY motif and binds to the Tyr292 negative regulatory phosphorylation site of ZAP-70.
    Lupher ML; Songyang Z; Shoelson SE; Cantley LC; Band H
    J Biol Chem; 1997 Dec; 272(52):33140-4. PubMed ID: 9407100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation.
    Bustelo XR; Crespo P; López-Barahona M; Gutkind JS; Barbacid M
    Oncogene; 1997 Nov; 15(21):2511-20. PubMed ID: 9399639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
    Jain SK; Langdon WY; Varticovski L
    Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling.
    Blake RA; Broome MA; Liu X; Wu J; Gishizky M; Sun L; Courtneidge SA
    Mol Cell Biol; 2000 Dec; 20(23):9018-27. PubMed ID: 11074000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cbl family of signal transduction molecules.
    Smit L; Borst J
    Crit Rev Oncog; 1997; 8(4):359-79. PubMed ID: 9622055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yeast two-hybrid in vivo association of the Src kinase Lyn with the proto-oncogene product Cbl but not with the p85 subunit of PI 3-kinase.
    Dombrosky-Ferlan PM; Corey SJ
    Oncogene; 1997 May; 14(17):2019-24. PubMed ID: 9160881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.